Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.
This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
The Contact Lens Institute and The Vision Council presented a sneak peek of its forthcoming report, “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success,” which will be published in mid-October 2023.
Postoperative scenario tracks potential complications.
Drop tolerance, adherence remain challenges for physicians and patients with glaucoma.
Andrew Pucker, OD, MS, PhD, FAAO, and George Magrath, MD, discuss Lexitas Pharma Services' work on modification of the National Eye Institute's corneal fluorescein staining scale.
The speed at which the COVID-19 vaccine was developed is the medical breakthrough of our lifetimes.
Paul Hahn, MD, PhD, shared insights on research comparing the relative efficacy of pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy presented at the 2023 ASRS annual meeting.
Corporate Optometry shares pearls on becoming a though leader in optometry.
Managing patient expectations is key to selecting the best lens
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Easy Anyama shares key takeaway points from "Vision care in the age of ChatGPT" and "Advances in AI and diagnosis for BIPOC populations" at Vision Expo West 2023 in Las Vegas.
Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.
Jack Phu, OD, MPH, PhD, with UNSW Sydney, discusses key takeaways from his AAOpt 2022 presentation that looked at visual fields in 2022.
Jennifer Tsai, OD, tells us how to start the conversation with patients about dual-wear, and the benefits of this from the patient and provider perspective.
ODs who utilize technology will advance modern optometric care.
Consider 4 conditions when treating this patient population.
Anthony Wallace, Vice President and General Manager of the US Surgical Business at Bausch + Lomb, discussed the introduction of SeeLuma, a fully digital surgical visualization platform, and more at the 2023 ASCRS annual meeting in San Diego.
Tackle one of the biggest challenges in managing patients with glaucoma
Mike Brown, OD, MHS-CL, FAAO, shares how the significance of a pocket watch and Helen Keller serve as important lessons in patient care for ODs.
ODs have the rare opportunity to engage as well as educate patients on hypertension.
By taking a proactive approach to treatment, identify the “silent sufferers.”
Jason Duncan, OD, FAAO, shares highlights from his AOA 2022 presentation, "Injection Basics," presented at this year's Optometry's Meeting in Chicago.
Hear about the new innovations on the market—and coming soon—from Alcon.
What the data shows on myopia management
Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.
The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.